CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome

Conditions:   Myelodysplastic Syndromes;   Graft Vs Host Disease;   Graft-versus-host-disease Interventions:   Drug: Busulfan;   Drug: Melphalan;   Drug: Fludarabine;   Device: CliniMACS CD34+ enriched, T-cell depleted peripheral blood stem cell (PBSC) Sponsor:   Baptist Health South Florida Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials